[Form 4] Equitable Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Robin Raju, Chief Financial Officer of Equitable Holdings, Inc. (EQH), reported insider transactions dated 09/22/2025. The Form 4 shows three linked transactions: two option exercises/awards that resulted in acquisition of 8,726 shares at an effective price of $18.74 and 17,162 shares at $23.18, and a sale of 36,888 shares at $54.00. After these transactions the reporting person’s beneficial ownership is reported as 140,257.89 shares. The derivative table clarifies the acquisitions stem from employee stock options exercisable with zero exercise price for reporting purposes and the acquired shares include Restricted Stock Units. The Form 4 is filed by one reporting person and signed by an attorney-in-fact on behalf of Robin Raju.

Positive

• Acquisitions of 8,726 shares at $18.74 and 17,162 shares at $23.18 on 09/22/2025 indicate exercise/vesting activity tied to employee compensation
• Restricted Stock Units included in reported beneficial ownership, as disclosed in the explanation

Negative

• Sale of 36,888 shares at $54.00 on 09/22/2025 reduced aggregate beneficial ownership to 140,257.89 shares
• Net decrease in holdings resulting from the combined transactions (acquisitions totaling 25,888 shares versus 36,888 shares sold)

Insights

Financial Analyst

TL;DR: Insider exercised options and sold shares, reducing holdings to 140,257.89 shares; transactions appear routine compensation-related activity.

The filing documents option-related acquisitions of 8,726 shares at $18.74 and 17,162 shares at $23.18 on 09/22/2025, and a contemporaneous sale of 36,888 shares at $54.00. The acquisitions derive from employee stock options and Restricted Stock Units tied to prior omnibus plan grants. The net effect is a decline in beneficial ownership to 140,257.89 shares. No new derivative grants or unusual vesting schedules are disclosed beyond the described multi-year vesting noted in the explanations.

Corporate Governance Expert

TL;DR: Transactions are documented under Section 16 reporting; disclosures identify role as CFO and note attorney-in-fact signature.

The Form 4 correctly identifies the reporting person as the issuer's Chief Financial Officer and indicates the filing was made by one reporting person. The form includes explanatory notes referencing prior Form 3 disclosure for initial option grants and clarifies vesting schedules. The signature block shows Michael Brudoley signed as attorney-in-fact on 09/23/2025, satisfying signature requirements for Form 4 submissions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Raju Robin M

(Last) (First) (Middle)

C/O EQUITABLE HOLDINGS, INC.

1345 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Equitable Holdings, Inc. [ EQH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/22/2025		M		8,726	A	$18.74	159,983.89(1)	D
Common Stock	09/22/2025		M		17,162	A	$23.18	177,145.89(1)	D
Common Stock	09/22/2025		S		36,888	D	$54	140,257.89(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$18.74	09/22/2025		M			8,726	(2)	02/14/2029	Common Stock	8,726	$0	0	D
Employee Stock Options (right to buy)	$23.18	09/22/2025		M			17,162	(3)	02/26/2030	Common Stock	17,162	$0	0	D

Explanation of Responses:

1. Includes Restricted Stock Units.

2. Grant of employee stock options under the Issuer's omnibus incentive plans. The options vested/vest in three equal annual installments beginning on February 14, 2020. The number of securities underlying the initial derivative security grant was reported on a Form 3 filing dated April 9, 2021. All other options under this grant were executed prior to Reporting Person's appointment to Section 16 Officer.

3. Grant of employee stock options under the Issuer's omnibus incentive plans. The options vested/vest in three equal annual installments beginning on February 26, 2021. The number of securities underlying the initial derivative security grant was reported on a Form 3 filing dated April 9, 2021. All other options under this grant were executed prior to Reporting Person's appointment to Section 16 Officer.

Remarks:

	Michael Brudoley as attorney-in-fact for Robin Raju	09/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did EQH CFO Robin Raju report on 09/22/2025?

The Form 4 reports acquisitions of 8,726 shares at $18.74 and 17,162 shares at $23.18, and a sale of 36,888 shares at $54.00.

What is Robin Raju's beneficial ownership after the reported trades?

After the transactions, beneficial ownership is reported as 140,257.89 shares.

Were the acquired shares from options or restricted stock?

The filing states the acquisitions derive from employee stock options and the totals include Restricted Stock Units.

Who signed the Form 4 on behalf of Robin Raju?

The Form 4 was signed by Michael Brudoley as attorney-in-fact for Robin Raju on 09/23/2025.

Does the filing indicate any new grants or unusual vesting terms?

The explanation references prior grants with three-year vesting beginning in 2020 and 2021; no new unusual grants or altered vesting terms are disclosed.